FDA approves blockbuster Dupixent for chronic hives

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Morning. Today, we talk lots about tariffs — how they might impact drugmakers, patients, and even Ireland. Also, Novo Nordisk challenges Medicare over drug differentiation, and more. 

Read the rest…

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs

Comments
Loading...